Cargando…
The evolution of alternative splicing in glioblastoma under therapy
BACKGROUND: Alternative splicing is a rich source of tumor-specific neoantigen targets for immunotherapy. This holds promise for glioblastomas (GBMs), the most common primary tumors of the adult brain, which are resistant to standard-of-care therapy. Although most clinical trials enroll patients at...
Autores principales: | Wang, Lin, Shamardani, Karin, Babikir, Husam, Catalan, Francisca, Nejo, Takahide, Chang, Susan, Phillips, Joanna J., Okada, Hideho, Diaz, Aaron A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835670/ https://www.ncbi.nlm.nih.gov/pubmed/33499924 http://dx.doi.org/10.1186/s13059-021-02259-5 |
Ejemplares similares
-
A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets
por: Wang, Lin, et al.
Publicado: (2022) -
MEDB-59. A draft atlas of medulloblastoma cellular evolution under therapy
por: Wang, Lin, et al.
Publicado: (2022) -
ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma
por: Babikir, Husam, et al.
Publicado: (2021) -
OTEH-11. Single Cell RNA Sequencing to identify cellular heterogeneity with in Pituitary Adenomas
por: Jain, Saket, et al.
Publicado: (2021) -
IMMU-23. A NOVEL MASS CYTOMETRY-BASED MULTI-PARAMETER CHARACTERIZATION OF NEOANTIGEN-REACTIVE CD8+ T-CELLS IN PATIENTS PARTICIPATING IN PNOC007 H3.3K27M PEPTIDE VACCINE CLINICAL TRIAL
por: Taitt, Jared, et al.
Publicado: (2020)